SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-22-023135
Filing Date
2022-02-14
Accepted
2022-02-14 17:07:16
Documents
2
Group Members
JEREMY C. GREENREDMILE CAPITAL OFFSHORE II MASTER FUND, LTD.REDMILE STRATEGIC MASTER FUND, LP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm226094d23_sc13ga.htm SC 13G/A 119182
2 EXHIBIT 99.1 tm226094d23_ex99-1.htm EX-99.1 9068
  Complete submission text file 0001104659-22-023135.txt   129982
Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Filed by) CIK: 0001425738 (see all company filings)

IRS No.: 208592298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801
Business Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801 (857) 444-0553
Ayala Pharmaceuticals, Inc. (Subject) CIK: 0001797336 (see all company filings)

IRS No.: 823578375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91506 | Film No.: 22634499
SIC: 2836 Biological Products, (No Diagnostic Substances)